Content Type: Article

  • California Governor Vetoes AB 3129

    California Governor Vetoes AB 3129

    ARTICLE / CLIENT ALERT

    California Governor Vetoes AB 3129

    September 30, 2024

    Read time: 2 min

    Key takeaways
    Overview

    California Governor Gavin Newsom vetoed AB 3129 on September 28, 2024. AB 3129 would have required private equity groups and hedge funds to notify, and receive the consent of, the California Attorney General for certain investments involving health care facilities, provider groups and providers doing business in California. In vetoing AB 3129, Gov. Newsom noted the Office of Health Care Affordability (OHCA) presently has authority under California law to analyze healthcare transactions that may significantly impact market competition or affordability. Rather than expanding the Attorney General’s authority as AB 3129 proposed, Gov. Newsom stated that it would be more appropriate for the State to rely on OHCA to oversee these transactions. The California legislature could attempt to override Gov. Newsom’s veto, but such a development is unlikely.

    Gov. Newsom’s veto statement may be found here.

    Visit our Health Transactions Resource Center for more coverage on AB 3129 and other regulations impacting health industry transactions.

    In depth
    Authors

    Travis Jackson

    Partner

    Los Angeles

    Joel C. Rush

    Partner

    Washington, DC

    More insights

  • FinCEN Issues Final AML/CFT Program Rule for Certain Investment Advisers

    FinCEN Issues Final AML/CFT Program Rule for Certain Investment Advisers

    ARTICLE / CLIENT ALERT

    FinCEN Issues Final AML/CFT Program Rule for Certain Investment Advisers

    September 30, 2024

    Read time: 34 min

    Key takeaways
    Overview

    On Sept. 4, 2024, the US Department of the Treasury’s Financial Crimes Enforcement Network (“FinCEN”) issued a long-awaited final rule extending the anti-money laundering/countering the financing of terrorism (“AML/CFT”) program and related requirements, such as suspicious activity reporting, to certain SEC-registered investment advisers (“RIAs”) and exempt reporting advisers (“ERAs,” and with RIAs, collectively, “Covered Advisers”) (“Final Rule”).[1]

    The Final Rule’s effective date is Jan. 1, 2026. This Alert outlines the scope of the Final Rule and the new obligations it will impose on Covered Advisers.

    Prior Rulemaking Attempts

    The Final Rule arrived nearly nine years after FinCEN last attempted similar AML regulations for RIAs in 2015,[2] and followed even earlier efforts by FinCEN in 2002 and 2003 to apply AML regulations to the asset management industry.[3] Although these proposed rules were never finalized, the asset management industry responded to them by implementing AML programs and investor due diligence measures on a voluntary basis. Over time, industry best practices developed that captured the requirements of the prior proposed rules. However, the Final Rule includes requirements that exceed prior proposed rules and industry best practices, as well as requirements that may be unfamiliar to many Covered Advisers — most notably the obligation to adopt and implement a risk-based written AML/CFT program and report suspicious activity to FinCEN.

    2024 Investment Adviser Sector-Wide Risk Assessment

    The Final Rule was issued following the results of the US Department of the Treasury’s February 2024 investment adviser sector-wide risk assessment (“2024 Risk Assessment”),[4] which was issued concurrently with its Feb. 15, 2024, notice of proposed rulemaking on AML/CFT program and Suspicious Activity Report (“SAR”) requirements for investment advisers (“Proposed Rule”).[5] The 2024 Risk Assessment found that, while the degree of illicit finance activity risk is not uniform across the entire investment adviser sector, Covered Advisers pose a material risk of misuse for illicit finance.[6] First, case examples in the Proposed Rule and 2024 Risk Assessment highlighted that a range of illicit actors view Covered Advisers as potential entry points into the US financial system, and many illicit actors have already sought to exploit them.[7] The 2024 Risk Assessment also noted that Covered Advisers’ compensation arrangements disincentivize the voluntary review of illicit finance risks presented by investors and investment arrangements. FinCEN explains that without an AML/CFT program requirement or an obligation to file SARs with FinCEN, Covered Advisers have no obligation to evaluate the risk of money laundering, terrorist financing (“ML/TF”), or other illicit activity associated with their advisory activities.[8]

    Scope of Investment Advisers Covered by the Final Rule

    The Final Rule adds “investment adviser” to the definition of “financial institution” under the Bank Secrecy Act’s (“BSA”) implementing regulations. While the Proposed Rule broadly defined “investment adviser” to include RIAs and ERAs, in the interest of balancing commenters’ concerns about the Proposed Rule’s potential burden on smaller investment advisers with the sector-wide illicit finance risks identified in the 2024 Risk Assessment, the Final Rule excludes:

    1. RIAs that register with the SEC solely because they are (i) mid-sized advisers, (ii) multi-state advisers or (iii) pension consultants.[9]
    2. RIAs that do not manage clients’ assets as part of their advisory activities and report zero AUM[10] to the SEC on Form ADV. FinCEN explained that the services provided by these advisers “may include non-discretionary financial planning (such as fee-only advice) and publication of securities-related newsletters, ‘model portfolios,’ or research reports.” These RIAs, FinCEN notes, “are generally unlikely to have sufficient information about a customer’s source of funds, background, and investment objectives to detect suspicious financial activity.”[11]

    Foreign-Located Covered Advisers

    The Final Rule also addresses commenters’ concerns about the Proposed Rule applying to RIAs or ERAs that have a principal office and place of business outside of the United States, particularly the reach of the rule to these advisers and the scope of activities covered. The Final Rule defines a “foreign-located investment adviser” as an “investment adviser whose principal office and place of business is outside the United States.”[12] The Final Rule sets forth the scope of the foreign-located Covered Adviser’s obligations, stating that it only applies to advisory activities that (i) take place within the United States, including through the involvement of US personnel[13] of the foreign-located Covered Adviser, such as the involvement of an agency, branch, or office within the United States or (ii) are provided to a US person or a foreign-located private fund with an investor that is a US person.[14] To determine whether an investment adviser is a foreign-located investment adviser for purposes of the Final Rule, the adviser must look to its “principal office and place of business,” which FinCEN considers to be the “executive office of the investment adviser from which the officers, partners, or managers of the investment adviser direct, control, and coordinate the activities of the investment adviser.”[15]

    With respect to a foreign-located Covered Adviser’s advisory services to a foreign-located private fund[16], the Final Rule requires such Covered Adviser to determine whether any such private fund that it advises has at least one investor who is a US person. If that private fund has at least one US person investor, the foreign-located Covered Adviser must apply the Final Rule with respect to that private fund.[17]

    State-Registered Investment Advisers

    Consistent with the Proposed Rule, the Final Rule does not apply to state-registered investment advisers.

    Foreign Private Advisers and Family Offices

    As in the Proposed Rule, the Final Rule does not apply to foreign private advisers or family offices as defined in the Advisers Act.[18]

    Requirements of the Final Rule

    1. AML/CFT Program

    Under the Final Rule, Covered Advisers are required to adopt and implement a risk-based written AML/CFT compliance program. Covered Advisers’ AML/CFT programs must include the following five minimum components as required by section 5318(h) of the BSA: (i) internal policies, procedures and controls that are reasonably designed to prevent the Covered Adviser from being used for ML/TF or other illicit finance activities; (ii) independent testing to be conducted by the Covered Adviser’s personnel or a qualified outside party; (iii) designation of a qualified AML/CFT compliance officer or committee; and (iv) an ongoing employee training program. We discuss each in turn below.

      1. Internal Policies, Procedures and Controls. The Final Rule requires Covered Advisers to establish and implement risk-based internal policies, procedures and controls reasonably designed to prevent the Covered Adviser from being used for ML/TF or other illicit finance activity.[19] In determining which policies, procedures and controls to implement, the Final Rule requires Covered Advisers to review the types of advisory services they provide and the nature of the customers they advise in order to understand their particular ML/TF and other illicit finance risks.[20] This approach is intended to provide Covered Advisers with flexibility in designing their AML/CFT program to be commensurate with the ML/TF risks presented by the Covered Advisers business—including the specific advisory services provided, the unique customer base and geographical reach. When assessing their independent risk profiles, Covered Advisers must consider the types of accounts they offer (e.g., managed accounts or private funds), the channel(s) through which such accounts are opened, the types of customers opening such accounts (e.g., individuals or entities with managed accounts, private funds, closed-end funds, or real estate funds), including their geographic location, sources of wealth and investment objectives.[21] The preamble to the Final Rule provided some guidance as to which funds may generally be considered lower risk (e.g., exchange listed, registered funds) or higher risk (e.g., private funds that do not disclose identifying information about the investors in a private fund). FinCEN identified exchange-listed registered closed-end funds as typically lower risk because they (a) do not offer their shares continuously or redeem their shares on demand; (b) issue a fixed number of shares, which typically trade at negotiated prices on a stock exchange or in the over-the-counter market; (c) do not have an account relationship with their investors; and (d) have shares that are purchased and sold through BSA-regulated financial institutions, such as banks and broker-dealers, which are required to verify the identity of their customers and obtain beneficial ownership from legal entity customers. FinCEN clarified that private funds are not categorically treated as low-risk for ML/TF because there are various factors that may influence the risk-profile of a private fund, such as the subscription amount, whether there are any restrictions on redemptions or withdrawals, the Covered Adviser’s investment strategy, the targeted investor base, jurisdictions involved, and currency used with investors. Where a private fund presents a higher risk of being used for ML/TF, FinCEN expects that a Covered Adviser will adopt and implement mitigating policies, procedures and internal controls, such as gathering information about the structure or ownership of the fund, and identifying information about the investors in the fund.
      2. Independent Testing. The Final Rule requires that Covered Advisers provide for independent testing of their AML/CFT programs by their own personnel or a qualified outside party.[22] The frequency of independent testing will depend on Covered Advisers’ ML/TF and other illicit finance activity risk profiles, in addition to their overall risk management strategies.[23] While Covered Advisers may use trained internal staff who are not involved in the function being tested, the AML/CFT officer, or any party who directly and, in some cases, indirectly reports to the AML/CFT compliance officer or AML/CFT compliance officer-equivalent role, will generally not be considered sufficiently independent for the purposes of the Final Rule.[24]
      3. Qualified AML/CFT Compliance Officer or Committee. The Final Rule requires that Covered Advisers designate a person or group of persons to be responsible for implementing and monitoring the internal policies, procedures and controls of their AML/CFT programs. Covered Advisers may designate a single person or persons (including a committee) to be responsible for AML/CFT compliance.[25] The designated individual or committee must be qualified to oversee the Covered Adviser’s compliance with the BSA and FinCEN’s implementing regulations.[26] Among other criteria, a qualified AML/CFT officer or committee must have sufficient knowledge and understanding of the Covered Adviser’s ML/TF and other illicit finance activity risks, the BSA and its implementing regulations, and how those laws and regulations apply to the Covered Adviser and its activities.[27] Additionally, an AML/CFT compliance officer or committee should have decision-making authority over the Covered Adviser’s AML/CFT program, and sufficient stature within the organization to ensure that the program meets the applicable requirements of the BSA.[28]
      4. Ongoing Employee Training Program. Under the Final Rule, employees of a Covered Adviser and any agent or third-party service provider that is tasked with administering any portion of such Covered Adviser’s AML/CFT program must be trained in the AML/CFT requirements relevant to the Covered Adviser’s functions.[29] The Final Rule requires that the employees of a Covered Adviser (and of any agent or third-party service provider that is charged with administering any portion of the AML/CFT program) must also be trained to recognize signs of ML/TF or other illicit finance activity that could arise in the course of their duties.[30] The frequency of periodic training will depend on the Covered Adviser’s risk profile and overall risk management strategy.[31] For other BSA-regulated financial institutions, AML/CFT training is typically provided on an annual basis. FinCEN assumes that approximately two-thirds of Covered Advisers’ employees will require training each year, which must include periodic updates and refresher training on AML/CFT compliance.[32]
      5. Risk-based Procedures for Conducting Ongoing Customer Due Diligence. The Final Rule requires that Covered Advisers’ AML/CFT programs include appropriate risk-based procedures for conducting ongoing customer due diligence (“CDD”) that includes (i) understanding the nature and purpose of customer relationships for the purpose of developing a customer risk profile and (ii) conducting ongoing monitoring to identify and report suspicious transactions and, on a risk basis, to maintain and update customer information.[33] The Final Rule does not require Covered Advisers to collect customer identifying information and verify that information, which will be addressed by FinCEN in a separate joint rulemaking with the SEC.[34] Nor does the Final Rule include a categorical requirement to collect beneficial ownership information (“BOI”) from legal entity customers. Instead, Covered Advisers are required to make a risk-based determination as to whether they need to collect a legal entity customer’s BOI based on the customer’s independent risk profile.[35] By comparison, banks and broker-dealers have an obligation to collect BOI from their legal entity customers.[36]

    Scope of Activities Covered by the Final Rule

    The Final Rule requires Covered Advisers to apply their AML/CFT program to all advisory services they provide. While the Final Rule does not define “advisory services,” the preamble explains that advisory services would include the management of customer assets and the submission of customer transactions for execution.[37] FinCEN has provided some relief as Covered Advisers are not required to apply their AML/CFT programs to advisory services where the customer is a mutual fund (including open-end exchange-traded funds), a collective investment fund established by a national bank and federal savings association, or another investment adviser[38] that is independently subject to the Final Rule.[39] FinCEN declined to include additional exclusions for:

    • European Société d’investissement à Capital Variable (“SICAV”)[40] vehicles (or other pooled investment vehicles administered by foreign financial institutions). FinCEN noted that although SICAVs may be subject to comparable AML/CFT regulation by foreign supervisory authorities, those regulations may not specifically address illicit finance risks to the US financial system or provide relevant information directly to US regulators or law enforcement.
    • Retirement plan participants. FinCEN explained that while such plans are subject to regulation and supervision under ERISA, exempting such participants would leave a material gap in addressing illicit finance risks. That is because retirement plans may not be offered directly through a financial institution with AML/CFT program, SAR and recordkeeping obligations under the BSA, and applying AML/CFT requirements to Covered Advisers to such plans, such as SAR filing requirements, may help identify illicit activity involving the theft or misappropriation of plan assets
    • Exchange-listed registered closed-end funds. FinCEN explained that while these funds are not categorically excluded from a Covered Adviser’s AML/CFT program, such funds can often be treated as lower risk because they are typically offered to retail investors through a broker-dealer, which performs customer identification and verification as well as CDD, with the Covered Adviser managing the investment portfolio of the fund.

    Implementation of AML/CFT Program Requirements

    Use of Third-Party Service Providers and Foreign Personnel. Covered Advisers may delegate the implementation and operation of some or all aspects of their AML/CFT program to a service provider, but the Covered Adviser will remain responsible for overall compliance with the requirements of the Final Rule. At this time, FinCEN has determined not to include in the Final Rule the provision implementing 31 U.S.C. § 5318(h)(5), which provides that the duty to establish, maintain and enforce AML/CFT programs must be the responsibility of, and be performed by, persons in the US who are accessible to, and subject to oversight and supervision by, the Secretary of the Treasury and the appropriate Federal functional regulator (“Duty Provision”).[41] FinCEN’s omission of the Duty Provision from the Final Rule is significant for foreign-located Covered Advisers that may have operations entirely outside the US and Covered Advisers that use third-party service providers, such as fund administrators, that are located outside the US. However, Covered Advisers should be aware that FinCEN continues to take the Duty Provision under advisement and may consider applying it to Covered Advisers in a subsequent rulemaking.[42]

    Board or Board-Equivalent AML/CFT Program Approval and Oversight. Under the Final Rule, a Covered Adviser’s AML/CFT program must be approved in writing by its board of directors or trustees. If the Covered Adviser does not have a board of directors or trustees, approval must come from individuals or groups with functions similar to a board of directors and with the authority to approve the Covered Adviser’s AML/CFT program. Such individuals may include: a Covered Advisers’ sole proprietor, general partner, CEO, CFO, COO, Chief Legal Officer, Chief Compliance Officer or Director.[43] Groups with AML/CFT program oversight responsibilities may include board committees, such as compliance committees or audit committees, or a group of some or all individuals with the aforementioned titles.[44]

    2. Reporting Requirements

    SARs. The Final Rule requires Covered Advisers to file a SAR with FinCEN for any suspicious transaction (or pattern of transactions) conducted or attempted by, at or through the Covered Adviser that involves or aggregates at least $5,000 in funds or other assets. Suspicious transactions are those that:

    • Involve funds derived from illegal activity or that are intended or conducted to hide or disguise funds or assets derived from illegal activity as part of a plan to violate or evade any Federal law or regulation or to avoid any transaction reporting requirement under Federal law or regulation;
    • Are designed, whether through structuring or other means, to evade the requirements of the BSA;
    • Have no business or apparent lawful purpose, and the Covered Adviser knows of no reasonable explanation for the transaction after examining the available facts; or
    • Involve the use of the Covered Adviser to facilitate criminal activity.[45]

    Covered Advisers will have 30 days from when a determination is made to electronically file the SAR with FinCEN by uploading it to FinCEN’s BSA E-filing database.

    FinCEN interprets “transactions conducted or attempted by, at, or through” to include a Covered Adviser’s “advisory activities on behalf of its clients.”[46] The Final Rule provides the following examples of activities occurring by, at, or through a Covered Adviser[47]:

    • When a Covered Adviser’s customer provides an instruction to the Covered Adviser for the Covered Adviser to pass on to the custodian (e.g., an instruction to withdraw assets, to liquidate particular securities or a suggestion that the adviser purchase certain securities for the customer’s account), or a Covered Adviser instructs a custodian to execute transactions on behalf of its client;
    • Transactions designed to hide the source or destination of funds and fraudulent activity;
    • An investor in a private fund, including a venture capital fund requesting access to detailed non-public technical information about a portfolio company the fund is invested in that is inconsistent with a professed focus on economic return, in a potential case of illicit technology transfer in violation of sanctions, export controls or other applicable law;
    • Funding a managed account or investing in a private fund by using multiple wire transfers from different accounts maintained at different financial institutions or requesting that a transaction be processed in a manner to avoid funds being transmitted through certain jurisdictions;
    • Unusual wire activity that does not correlate with a customer’s stated investment objectives;
    • Transferring funds or other assets involving the accounts of third parties with no plausible relationship to the customer, transfers of funds or assets involving suspicious counterparties—such as those subject to adverse media, exhibiting shell company characteristics or located in jurisdictions with which the customer has no apparent nexus;
    • The customer behaving in a manner that suggests that the customer is acting as a “proxy” to manage the assets of a third party;
    • An unusual withdrawal request by a customer with ties to activity or individuals subject to US sanctions following or shortly prior to news of a potential sanctions listing;
    • Potential fraud and manipulation of customer funds directed by the investment adviser, such as insider trading, market manipulation or an unusual wire transfer request by an investment adviser from a private fund’s account held for the fund’s benefit at a qualified custodian.
    • With regard to portfolio companies: where the Covered Adviser: (i) is approached by an investor in a fund about unusual access to particular technology or processes being developed by a portfolio company, (ii) becomes aware that such investor has reached out to a portfolio company for such information, or (iii) is asked to obscure participation by an investor in a particular transaction to avoid notification to government authorities.

    The Final Rule also makes clear, however, that non-advisory activities of a Covered Adviser are not in scope of a Covered Adviser’s SAR filing obligation.

    SAR Confidentiality. SARs are subject to strict confidentiality. The Final Rule allows Covered Advisers and their agents to disclose the underlying facts, transactions and documents upon which a SAR is based; provided that no person involved in the reported transaction is notified that the transaction has been reported.[48] Covered Advisers or any current or former directors, officers, employees, or agents of a Covered Adviser are prohibited from disclosing a SAR or any information that would reveal the existence of a SAR except in the following three circumstances.[49]

    • To FinCEN, or any Federal, State, or local law enforcement agency, or any Federal regulatory authority that examines the Covered Adviser for compliance with the BSA.
    • Where: (i) the Covered Adviser and the recipient entity or entities are jointly filing a SAR or (ii) the disclosure is in connection with certain employment references or termination notices.[50]
    • Within a Covered Adviser’s corporate organizational structure for purposes consistent with the BSA as determined by regulation or in guidance.[51] FinCEN has yet to release any regulation or guidance that would permit a Covered Adviser to share SARs within its corporate organizational structure.[52]

    CTRs. Under the Final Rule, Covered Advisers are required to file CTRs for transactions in currency over $10,000.[53] Given that Covered Advisers do not typically engage in currency transactions, complying with the CTR filing obligation should not be burdensome. The CTR filing obligation replaces the obligation to file a Form 8300 for the receipt of more than $10,000 in currency and certain negotiable instruments requirement.[54]

    The requirement to file other reports under the BSA, such as FBARs, remains unchanged.

    3. Enhanced Due Diligence For High-Risk Customers

    The Final Rule will require Covered Advisers to adopt special standards of due diligence for correspondent accounts and private banking accounts that are reasonably designed to enable the Covered Adviser to detect and report any known or suspected money laundering or suspicious activity conducted through or involving any such accounts.[55]

    Correspondent Accounts. The special due diligence requirements for correspondent accounts[56] will apply to any Covered Adviser that provides foreign financial institutions (“FFIs”) “with a conduit for engaging in ongoing transactions in the U.S. financial system.” Only those relationships between a Covered Adviser and a FFI that provide ongoing services are included in this requirement—isolated or infrequent transactions between a Covered Adviser and a FFI are excluded. Such special due diligence requirements include obtaining and considering information relating to the FFI’s AML program; obtaining the identity of any person with authority to direct transactions through any correspondent account that is a payable-through account (and the sources and beneficial owner(s) of funds or other assets in the payable-through account); determining whether the FFI in turn maintains correspondent accounts for other FFIs; and determining, for any correspondent account established or maintained for a FFI whose shares are not publicly traded, the identity of each owner of the FFI and the nature and extent of each owner’s ownership interest. FinCEN expects to issue additional guidance on this topic to aid Covered Advisers in complying with this requirement.

    Private Bank Accounts. The Final Rule extends special due diligence requirements for private bank accounts to Covered Advisers and requires Covered Advisers to adopt policies, procedures and controls which enable Covered Advisers to detect and report suspicious activity involving
    high-net-worth foreign persons with private bank accounts. These special due diligence requirements will apply to accounts for which a Covered Adviser manages at least $1 million in funds or assets (including in a private fund) for the benefit or on behalf of a non-US individual who is the direct or beneficial owner of the account and involves services provided by an employee or agent of the Covered Adviser acting as a liaison to such non-US individual. The discussion in the preamble regarding how to apply this rule to Covered Advisers is quite limited and we expect FinCEN to issue clarifying guidance on this point. Based on the application of this special due diligence rule to other financial institutions, we expect that it will require Covered Advisers to adopt measures for ascertaining the identity of all nominal and beneficial owners of a private banking account; ascertaining whether any such nominal or beneficial owner is a senior foreign political figure (“SFPF”) or family member or close associate of a SFPF; ascertaining the source(s) of funds deposited into a private banking account and the purpose and expected use of the account; and reviewing the activity of the account to ensure that it is consistent with the information obtained about the accountholder’s source of funds and the stated purpose and expected use of the account.

    4. Special Information Sharing Procedures

    The Final Rule applies sections 314(a) and 314(b) of the USA PATRIOT Act to Covered Advisers.[57]

    Section 314(a). Section 314(a) requires Covered Advisers, upon FinCEN’s request, to search their records for specified information to determine whether the Covered Adviser maintains or has maintained any account for, or has engaged in any transaction with, an individual, entity, or organization named in FinCEN’s request.[58] Covered Advisers must report any such identified information to FinCEN.[59] For purposes of section 314(a) requests, FinCEN does not expect Covered Advisers to have accounts for the underlying investors in a private fund unless the Covered Adviser has a separate advisory relationship with that underlying investor, such as, for example, a managed account relationship.[60] The Final Rule permits Covered Advisers to exclude from the section 314(a) information requirement mutual funds, bank- and trust company-sponsored collective investment funds and any other investment adviser they advise that is already subject to obligations under the BSA.

    Section 314(b). Section 314(b) allows Covered Advisers to participate in voluntary information-sharing arrangements with other BSA-regulated financial institutions, through which they are able to gather additional information to help them mitigate ML/TF and other illicit finance risks.[61] To participate in the section 314(b) information-sharing program, Covered Advisers must first register with FinCEN’s Secure Information Sharing System if they are not already a registered user of the system.[62]

    5. Special Measures

    The Final Rule extends the requirements of Section 311 of the USA PATRIOT Act and Section 9714(a) of the Combatting Russian Money Laundering Act to Covered Advisers. Covered Advisers will be required to implement “special measures” if the Secretary of the Treasury determines that a foreign jurisdiction, institution, class of transaction or type of account is of “primary money laundering concern.”[63] Special measures include imposing additional recordkeeping, information collection and reporting requirements, as well as prohibitions or conditions on the opening or maintenance of certain correspondent accounts.[64] Covered Advisers will be subject to the special measures requirements with respect to customers that are not mutual funds, collective investment funds or other investment advisers they advise that are independently subject to the Final Rule.[65]

    6. Recordkeeping

    AML/CFT-Related Record Retention Requirement. The Final Rule requires Covered Advisers to maintain, for a period of five years: (i) AML/CFT-related records, such as a written AML/CFT program that includes internal policies, procedures and controls, as well as records of certain transactions and transfers of funds specified in subpart D of the Final Rule and (ii) copies of filed SARs and underlying supporting documentation.[66]

    Transaction Records Under the Funds Transfer Travel Rule. The Final Rule extends the Recordkeeping and Travel Rules to Covered Advisers.[67] The Recordkeeping and Travel Rules require financial institutions to create and retain records for transmittals of funds and ensure that certain information pertaining to the transmittal of funds “travels” with the transmittal to the next financial institution in the payment chain.[68] Under the Recordkeeping and Travel Rules, Covered Advisers will be required to: (i) obtain and retain records for extensions of credit and cross-border transfers of currency, monetary instruments, checks, investment securities and credit in excess of $3,000 for a period of five years and (ii) pass on this information to the next financial institution in the payment chain.[69] “Transmittal of funds” includes funds transfers processed by banks, as well as similar payments where one or more of the financial institutions processing the payment (i.e., the transmitter’s financial institution, an intermediary financial institution, or the recipient’s financial institution) is not a bank. It is still unclear how the Travel Rule will apply to Covered Advisers.

    Under the Recordkeeping and Travel Rules, a transmitter’s financial institution must obtain and retain the name, address and other information about the transmitter and transaction for the same five-year period. The Recordkeeping and Travel Rules also require the recipient’s financial institution (and in some instances, the transmitter’s financial institution) to obtain and retain identifying information on the recipient for the same five-year period.[70]

    Delegation of Examination Authority to the SEC

    In the Final Rule, FinCEN delegated examination authority to the SEC over Covered Advisers’ compliance with the Final Rule. [71] The delegation reflects FinCEN’s recognition that the SEC is best equipped to handle such examinations given the existing SEC regulatory and examination apparatus with respect to investment advisers.

    This is consistent with FinCEN’s existing delegation of its examination authority to the SEC to examine broker-dealers and mutual funds for compliance with BSA implementing regulations meant to maintain efficiencies and avoid duplication.[72]

    Additional Rulemakings

    There are several rules that have been proposed or are yet to be proposed that will have an impact on Covered Advisers and may supplement this Final Rule.

    Customer Identification Program Rule. With respect to customer identification programs (“CIP”), on May 21, 2024 FinCEN and the SEC published a joint notice of proposed rulemaking to apply CIP requirements to Covered Advisers (“CIP Proposed Rule”).[73] The comment period for the CIP Proposed Rule closed on July 22, 2024, and FinCEN and the SEC are currently reviewing comments as they work toward finalizing this rule.[74] Notably, the CIP Proposed Rule includes a provision permitting Covered Advisers to rely on other financial institutions to perform CIP subject to certain conditions, including that the financial institution is subject to a rule implementing the AML/CFT program requirements of 31 U.S.C. section 5318(h) and is regulated by a Federal functional regulator.[75]

    Customer Due Diligence Rule. On May 11, 2016, FinCEN published a Final Rule imposing CDD requirements on financial institutions, including Covered Advisers (the “CDD Rule”).[76] As part of Congressional efforts to harmonize the BOI reporting requirements across financial institutions, the Corporate Transparency Act requires FinCEN to rescind the information collection requirements of the CDD Rule by January 1, 2025.[77] Thus, Covered Advisers will not be required to identify and verify the beneficial owners of legal entity customer accounts until the effective date of the revised CDD Rule.

    AML Program Effectiveness Rule. FinCEN notes that the AML/CFT program requirements for Covered Advisers in the Final Rule do not yet incorporate the AML/CFT program amendments directed by Section 6101(b) of the Anti-Money Laundering Act of 2020 and included in a FinCEN notice of proposed rulemaking published on July 3, 2024.[78] Once this rule is finalized, it may be extended to Covered Advisers. The Final Rule does currently require Covered Advisers to develop AML/CFT programs based on their own business structures.[79] Accordingly, Covered Advisers are required to identify their exposure to ML/TF and other illicit finance activity risks; understand the BSA requirements applicable to them; identify the risk factors relating to these requirements; design internal policies, procedures and controls that are required to reasonably assure compliance with these requirements; and periodically assess the effectiveness of these procedures and controls.[80]

    Takeaways and Next Steps

    Covered Advisers should review the Final Rule carefully because it will add significant compliance obligations and contains many requirements that exceed industry best practices. Covered Advisers should begin taking steps toward compliance with the Final Rule by the effective date of Jan. 1, 2026, including by:

    • Reviewing existing AML/CFT policies and procedures to determine whether any elements must be added to ensure compliance with the new requirements of the Final Rule, including, for example, formalizing delegation of certain compliance measures to third-party service providers, including administrators, and oversight of such third-party service providers, adding specific procedures for filing and maintaining confidentiality of SARs, and implementing risk-based procedures for conducting due diligence on different investor-types;
    • Evaluating whether procedures for collecting information from investors need to be revised and/or tailored based on the money laundering and terrorist financing risks presented by particular types of investors, e.g., a fund-of-funds domiciled in a high-risk jurisdiction, a nominee investing on behalf of an undisclosed principal or legal entity customer with a SFPF as its beneficial owner; this may require a formal risk assessment to be done;
    • Appointing a dedicated AML/CFT compliance officer (which may be satisfied by training an existing compliance professional to properly execute that role at the Covered Adviser);
    • Developing and implementing an AML/CFT training program, taking into consideration which employees should be trained, the content of such training and how to document such training;
    • Adopting a formal process for conducting independent testing, as well as determining the frequency of such independent testing;
    • Reviewing existing contracts with third-party service providers, such as administrators, to ensure that such contracts include the requirements of the Final Rule, including escalation of suspicious activity to Covered Advisers and proper recordkeeping. Such agreements should set forth the level of oversight and testing that the Covered Adviser should apply to the third-party service provider. Specifically, FinCEN clarifies in the Final Rule that it would not be sufficient to simply obtain a certification from a service provider that the service provider “has a satisfactory AML program” although a Covered Adviser could take into account such a certification as part of the Covered Adviser’s periodic oversight of the service provider’s operations;
    • Formally approving the written AML/CFT program by senior management and documenting that approval; and
    • Preparing for additional final rules from FinCEN that may require further modifications to Covered Advisers’ AML/CFT programs, including the CIP Proposed Rule, revised CDD Rule and AML Program Effectiveness Rule. Covered Advisers will likely need to further update their risk-based policies procedures and internal controls upon publication of the forthcoming final rules.

    Schulte attorneys have deep experience in this area and have been assisting asset managers with their  AML/CFT compliance needs for over 20 years.

    Authored by Michael S. Didiuk, Melissa G.R. Goldstein, Betty Santangelo, Kyle B. Hendrix and Noah A. Wright.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] Final Rule, Anti-Money Laundering/Countering the Financing of Terrorism Program and Suspicious Activity Report Filing Requirements for Registered Investment Advisers and Exempt Reporting Advisers, 89 Fed. Reg. 72156 (Sept. 4, 2024); see also FinCEN, Investment Adviser Final Rule Fact Sheet (August 28, 2024) (hereinafter, “IA Final Rule Fact Sheet”).

    [2] FinCEN, Notice of Proposed Rulemaking, Anti-Money Laundering Program and Suspicious Activity Report Filing Requirements for Registered Investment Advisers, 80 Fed. Reg. 52680 (Sept. 1, 2015). FinCEN withdrew this notice of proposed rulemaking upon issuing its new Proposed Rule in 2024.

    [3] On Sept. 26, 2002, FinCEN issued a proposed rule requiring unregistered investment companies, including private funds, to establish AML programs. FinCEN, Notice of Proposed Rulemaking, Anti-Money Laundering Programs for Unregistered Investment Companies, 67 Fed. Reg. 60617 (Sept. 26, 2002). On May 5, 2003, FinCEN issued another proposed rule requiring certain investment advisers to establish AML programs. FinCEN, Notice of Proposed Rulemaking, Anti-Money Laundering Programs for Investment Advisers, 68 Fed. Reg. 23646 (May 5, 2003). In June 2007, FinCEN announced that it was reviewing the broader AML regulatory framework and, as part of that review, rescinded these proposed rules on Nov. 4, 2008. FinCEN, Withdrawal of the Notice of Proposed Rulemaking, Anti-Money Laundering Programs for Investment Advisers, 73 Fed. Reg. 65568 (Nov.4, 2008).

    [4] Treasury, 2024 Investment Adviser Risk Assessment (February 2024).

    [5] FinCEN, Notice of Proposed Rulemaking, Anti-Money Laundering/Countering the Financing of Terrorism Program and Suspicious Activity Report Filing Requirements for Registered Investment Advisers and Exempt Reporting Advisers, 89 Fed. Reg. 12108. (Feb. 15, 2024). For more information regarding the Proposed Rule, please see our prior Alert, “FinCEN Once Again Proposes Anti-Money Laundering Program Requirements for Investment Advisers”.

    [6] Final Rule, 89 Fed. Reg. at 72159 (citing 2024 Risk Assessment at 32).

    [7] Final Rule, 89 Fed. Reg. at 72163; see also National Counterintelligence and Security Center, Safeguarding Our Innovation, 1 (July 24, 2024).

    [8] Final Rule, 89 Fed. Reg. at 72163.

    [9] FinCEN notes that, should the registration status of an RIA change such that the RIA would no longer be exempt from the definition of ‘‘investment adviser,’’ the adviser will become subject to the AML/ CFT requirements in this rule as of its next annual updating amendment to Form ADV. Final Rule, 89 Fed. Reg. at 72170.

    [10] While FinCEN in the preamble uses “AUM” (assets under management), the correct term as used by the SEC in Form ADV and for purposes of the Investment Advisers Act of 1940 is “RAUM” or “Regulatory Assets Under Management.”

    [11] Final Rule, 89 Fed. Reg. at 72168.

    [12] Final Rule, 89 Fed. Reg. at 72172 (citing 31 C.F.R. § 1032.110).

    [13] For the purposes of the Final Rule, “U.S. personnel” means, regardless of citizenship, any director, officer, employee, or agent of the investment adviser conducting advisory activities from a US agency, branch, or office of the investment adviser. Final Rule, 89 Fed. Reg. at 72172. US personnel would be involved in advisory activities if, for example, an employee of the investment adviser manages assets of a client from a US office or other US workplace of the investment adviser, or if the employee works remotely from the United States on a regular basis. Id. Conversely, a US citizen employee of the investment adviser managing assets of a client from a non-US office of the foreign-located investment adviser would generally not constitute US personnel involved in advisory activities for this purpose. Id.

    [14] Final Rule, 89 Fed. Reg. at 72173 and 72200. In contrast, an adviser with its principal office and place of business in the United States must comply with the Final Rule with respect to all of its advisory activities. Id. at 72172, n.122.

    [15] Final Rule, 89 Fed. Reg. at 72172.

    [16] The Final Rule defines “foreign-located private fund” by reference to Section 202(a)(29) of the Advisers Act, which defines “private fund” to mean “an issuer that would be an investment company, as defined in section 3 of the [Investment Company of 1940], but for section 3(c)(1) or 3(c)(7) of the Act.” Id. at 72173. The “foreign-located” aspect of the definition refers to a fund that is a legal entity or arrangement that is incorporated or organized outside the United States and therefore is not a US person for purposes of the Final Rule. Id.

    [17] FinCEN, in the preamble, notes that a “U.S.-located private fund advised by a foreign-located investment adviser is itself a U.S. person under this definition, and so a foreign-located investment adviser will also be required to apply the [F]inal [R]ule with respect to any U.S.-located private fund it advises, irrespective of the presence or absence of any U.S. person investors in such U.S.-located private fund.” Final Rule, 89 Fed. Reg. at 72173, n.132.

    [18] See 15 U.S.C. 80b–2(a)(11)(G) (excluding family offices as defined by the SEC from the Advisers Act definition of ‘‘investment adviser’’); 15 U.S.C. 80b–3(b)(3) (exempting foreign private advisers from registration with the SEC).

    [19] Final Rule, 89 Fed. Reg at 72191.

    [20] Id.

    [21] Id.

    [22] Id. at 72192.

    [23] Id.

    [24] Id.

    [25] Id. at 72193.

    [26] Id.

    [27] Id.

    [28] Id.

    [29] Id.

    [30] Id.

    [31] Id. at 72193, n.224.

    [32] Id. at 72230, n.361.

    [33] Id. at 72193.

    [34] Id. at 72194.

    [35] Id.

    [36] Id. at 72200, n.245.

    [37] Id. The preamble also explains that Covered Advisers need not apply their AML/CFT to non-advisory services. Id. at 72181. One example of non-advisory services would be in the context of private funds, including venture capital funds: an adviser’s personnel may play certain roles with respect to the portfolio companies in which its customer fund invests. Id. Generally, activities undertaken in connection with those roles (e.g., making managerial/operational decisions about the activities of portfolio companies) would not be “advisory activities.” Id.

    [38] As applied to sub-advisers, the preamble explains, this exclusion will permit an investment adviser (acting as sub-adviser) to exclude from its AML/CFT program another investment adviser (the primary adviser) to which it provides sub-advisory services where the sub-adviser has a direct contractual relationship with the primary adviser and not with the underlying customer of that primary adviser. Id. at 72184. The investment adviser may also be able to exclude wrap-fee programs, separately managed accounts, or other advisory relationships, so long as the customer is another investment adviser (as defined in the Final Rule) and the adviser does not have a direct contractual relationship with the underlying customer of the other investment adviser. Id.

    [39] Id. at 72181.

    [40] SICAVs are a type of collective investment fund commonly used in Europe. Id. at 72185 n.206.

    [41] Final Rule, 89 Fed. Reg. at 72197.

    [42] Id. at 72198.

    [43] Id. at 72197.

    [44] Id.

    [45] Id. at 72199 (citing 31 C.F.R. § 1032.320(a)(2)(i)-(iv)).

    [46] Id. at 72200.

    [47] Id.

    [48] Id. (citing 31 C.F.R. § 1032.320(d)(1)(ii)(A)(1)).

    [49] Id. at 72202.

    [50] Id. (citing 31 C.F.R. § 1032.320(d)(1)(ii)(A)(2)).

    [51] Id.

    [52] Id. (citing 31 C.F.R. § 1032.320(d)(1)(ii)(B)).

    [53] Id. at 72214.

    [54] Id.

    [55] Id.; see also 31 C.F.R. § 1010.610 through § 1010.620.

    [56] The term account, in the phrase “correspondent account,” includes “any contractual or other business relationship established between a person and an investment adviser to provide advisory services.” Final Rule, 89 Fed. Reg. at 72274.

    [57] Id. at 72204; FinCEN, USA PATRIOT Act Section 314(a) Fact Sheet (last updated Sept. 3, 2024); FinCEN, USA PATRIOT ACT Section 314(b) Fact Sheet (last updated December 2020).

    [58] Final Rule, 89 Fed. Reg. at 72204.

    [59] Id.

    [60] Id. at 72205. At this time, Covered Advisers are not specifically required to collect BOI for private funds. Therefore, when responding to a section 314(a) request on behalf of a private fund, Covered Advisers will typically need to provide information only about the private fund itself, not about its underlying investors.

    [61] Final Rule, 89 Fed. Reg. at 72196; see also USA PATRIOT Act Section 314(b) Fact Sheet at 1.

    [62] USA PATRIOT ACT Section 314(b) Fact Sheet at 6.

    [63] Final Rule, 89 Fed. Reg. at 72237.

    [64] Id.

    [65] Id. at 72206.

    [66] Id. (citing 31 C.F.R. § 1010.410).

    [67] Id. at 72156.

    [68] Id. at 72180.

    [69] Id. at 72179 (citing 31 C.F.R. § 1010.410(e), (f); 31 C.F.R. § 1020.410(a)).

    [70] Id. at 72180.

    [71] Id. at 72207 (citing 31 C.F.R. § 1010.810(b)(6)).

    [72] IA Final Rule Fact Sheet at 3.

    [73] Final Rule, 89 Fed. Reg. at 72161 (citing FinCEN and SEC, Joint Notice of Proposed Rulemaking, Customer Identification Programs for Registered Investment Advisers and Exempt Reporting Advisers, 89 Fed. Reg. 44571 (May 21, 2024)); for more information regarding the CIP Proposed Rule, please see our prior Alert, “FinCEN Issues Proposed Rule Requiring Customer Identification Programs for Investment Advisers.”

    [74] Final Rule, 89 Fed. Reg. at 72161.

    [75] Id. at 72195.

    [76] FinCEN, Final Rule, Customer Due Diligence Requirements for Financial Institutions, 81 Fed. Reg. 29398 (May 11, 2016).

    [77] Pub. L. 116–283, div. F, title LXIV, § 6403(d), 134 Stat. 4624 (Jan. 1, 2021).

    [78] IA Final Rule Fact Sheet at 3; for more information regarding the proposed pule, please see our prior Alert, “FinCEN Issues Proposed Rule to Strengthen and Modernize AML/CFT Programs for Financial Institutions.”

    [79] Final Rule, 89 Fed. Reg. at 72181.

    [80] Id.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2024 Schulte Roth & Zabel LLP. All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Melissa G.R. Goldstein

    Partner

    New York – 919 Third Avenue

    Betty Santangelo

    Counsel

    New York – 919 Third Avenue

    Kyle B. Hendrix

    Associate

    Washington, DC

    More insights

  • Third Circuit Orders Solvent Debtor to Pay Noteholders Post-Petition Interest at the Contract Rate, Including Make-Whole Premiums in Hertz Bankruptcy

    Third Circuit Orders Solvent Debtor to Pay Noteholders Post-Petition Interest at the Contract Rate, Including Make-Whole Premiums in Hertz Bankruptcy

    ARTICLE / CLIENT ALERT

    Third Circuit Orders Solvent Debtor to Pay Noteholders Post-Petition Interest at the Contract Rate, Including Make-Whole Premiums in Hertz Bankruptcy

    September 30, 2024

    Read time: 9 min

    Key takeaways
    Overview

    On Sept. 10, 2024, the US Court of Appeals for the Third Circuit struck down a Delaware bankruptcy court ruling that a solvent debtor could pay its noteholders’ interest at the lower federal judgment rate (a codified and typically lower interest rate), as opposed to a higher contract rate, and that the debtor need not pay contractual “make-whole” payments. The debtor, The Hertz Corporation, sought to uphold the bankruptcy court’s ruling because the contractual default rate would require the company to pay unsecured noteholders $260 million in post-petition interest, as well as additional “make-whole” premiums. The Third Circuit held that (1) make-whole premiums constitute post-petition unmatured interest, which is not typically allowed under the Bankruptcy Code, but (2) the Bankruptcy Code requires solvent debtors to pay unimpaired creditors’ post-petition interest at an equitable rate – in this case, the contract rate, and all other contractual obligations, including the make-whole payments – before making payments to equity holders as a matter of equity and fairness. See In re The Hertz Corporation, et al., No. 23-1169 (3d Cir. Jan. 27, 2023).

    Background

    Hertz, a car rental company, filed for Chapter 11 on May 22, 2020, in the middle of the COVID-19 pandemic. The economy recovered considerably over the next year, allowing Hertz to become solvent and propose a Chapter 11 plan that purportedly paid all creditors “in full” and paid $1.1 billion to its pre-bankruptcy stockholders.

    Prior to filing for bankruptcy, Hertz issued nearly $1.4 billion in unsecured notes. The notes’ indentures contained make-whole premiums, each triggered upon the acceleration of the debt resulting from Hertz’s bankruptcy filing. A make-whole premium is a contractually agreed-upon payment that is triggered when a borrower repays the loan prior to the maturity date. Make-whole premiums compensate lenders for the time they will not earn interest as a result of an early repayment.

    The plan purported to leave the noteholders’ claims unimpaired – which, under the Bankruptcy Code, requires their “legal, equitable, and contractual rights” to be “unaltered.” Moreover, under Bankruptcy Code section 1126(f), the Debtors deemed the Noteholders to automatically accept the plan based on their status as unimpaired creditors.

    The plan proposed to pay creditors post-petition interest – at the federal judgment rate, rather than the contract rate provided under the notes – which resulted in the noteholders receiving approximately $260 million less than what they were contractually entitled to receive. The plan provided that the noteholders were not entitled to receive any make-whole premiums.

    The noteholders objected to the plan and argued that it impaired their claims. Once the plan was confirmed, the noteholders sought payment of post-petition interest at the contract rate and make-whole premiums.

    The Bankruptcy Court dismissed the noteholders’ make-whole claims on the grounds that section 502(b)(2) of the Bankruptcy Code disallows such claims as unmatured interest. The Bankruptcy Court also dismissed the Noteholders’ request for contract rate interest, holding that the federal judgment rate was appropriate.

    The Bankruptcy Court overruled the noteholders’ objections, confirmed the plan and certified the case for direct appeal to the Third Circuit.

    Decision

    In a 2-1 ruling on Sept. 10, 2024, the Third Circuit Court of Appeals, in an opinion written by Judge Thomas Ambro, addressed two key issues: 1) “Does § 502(b)(2)’s prohibition on claims ‘for unmatured interest’ cover make whole fees . . .” and 2) “[D]oes the Bankruptcy Code as a whole require solvent debtors to pay impaired creditors interest accruing post-petition at the contract rate?”

    Are Make-Wholes Permitted Under section 502(b)(2) of the Bankruptcy Code?

    First, the Third Circuit analyzed whether the noteholders’ claim should include the make-whole premiums. Hertz argued that make-whole premiums must be disallowed under Bankruptcy Code section 502(b)(2). Section 502(b)(2) of the Bankruptcy Code states that a court will not allow claims for “unmatured interest.” Hertz asserted that the make-whole premium serves the same economic function as interest by compensating for the risk and delay in repayment of the monies they owe to the noteholders but remains unmatured at the date of the bankruptcy filing and thus is prohibited under section 502(b)(2) of the Bankruptcy Code.

    The noteholders argued that make-whole premiums should be allowed because the Bankruptcy Code does not define interest and make-wholes do not match the ordinary meaning of interest – compensation for the use or forbearance of money based on caselaw and the dictionary definition of the term.

    The Third Circuit found that make-whole premiums “fit both the dictionary definition of interest and are its economic equivalent.” In reaching this conclusion, the majority agreed with Hertz’s reasoning that the make-whole premiums “are mathematically equivalent to the unmatured interest the Noteholders would have received had Hertz redeemed the Notes on their Redemption Dates.” The Third Circuit further explained that make-whole premiums fall within the definition of interest because make-whole premiums “are among the suite of fees [the noteholders] extracted from Hertz in return for their credit[,]” such that “Hertz’s commitment to pay them was ‘compensation’ for its use of [the noteholders’] funds.” Therefore, the Court held that the make-whole premiums constitute disallowed unmatured interest.

    Does the Bankruptcy Code as a whole require payment of all post-petition interest?

    Next, the Third Circuit turned to the issue of whether the noteholders should receive post-petition interest at the contract rate under the notes, including the make-whole premiums, because Hertz was a solvent debtor. Judge Ambro characterized the issue as, “Can [solvent] Hertz use the Bankruptcy Code to force Noteholders to give up nine figures of contractually valid interest and spend that money on a massive dividend to Stockholders? The answer is no.”

    The Third Circuit grounded its analysis of this issue in the “absolute priority rule,” which requires that all creditors must be paid in full prior to there being any return to equity. This is “bankruptcy’s most important and famous rule[.]” The Third Circuit referred to the Supreme Court’s 19thCentury decision in Chi Rock Island & Pac R.R. to reiterate that “the rule is well settled that stockholders are not entitled to any share . . . until all the debts of the corporation are paid.”

    The absolute priority rule exists in the Bankruptcy Code in section 1129(b). However, the Supreme Court in 2017 made clear that the absolute priority rule applies to all aspects of bankruptcy. In Jevic Holding Corp. the Supreme Court (reversing the Third Circuit) made clear that the absolute priority rule “entitles every creditor . . . to treatment consistent with absolute priority.” For a solvent debtor to comply with the absolute priority rule, before the debtor can make any distribution, creditors must recover everything that they are entitled. This policy preceded implementation of the Bankruptcy Code in 1978, and therefore remains in place because the Bankruptcy Code does not expressly reject it.  

    Here, the Third Circuit applied this reasoning to declare that the debtors must pay the noteholders the full amount of their post-petition interest – make-wholes included – in a solvent debtor case before making any distributions to equity.

    Hertz nevertheless argued that, irrespective of the absolute priority rule, the noteholders are entitled to post-petition interest at the federal judgment rate, rather than the contract rate. Hertz argued that Bankruptcy Code section 726(a)(5), which allows unsecured creditors of solvent debtors to be paid post-petition interest “at the legal rate[,]” mandates this result.

    The noteholders argued that the pre-Bankruptcy Code’s “solvent debtor exception” when read with the absolute priority rule, required solvent debtors, such as Hertz, to pay post-petition interest to creditors at the contract rate (here including the contractual make-wholes”). The solvent debtor exception is an equitable remedy requiring that a solvent debtor pay post-petition interest to dissenting unsecured creditors in Chapter 11 proceedings, which arises out of caselaw from before the Bankruptcy Code.

    Case law under the “solvent debtor exception” “required solvent debtors to pay contract rate interest before making distributions to equity.” The Third Circuit noted: “That makes sense. . . . The absolute priority rule requires creditors’ obligations to be paid before owners . . . take anything at all. So it should be no surprise that several thoughtful decisions conclude that the Bankruptcy Code’s absolute priority rule, which incorporates common law and Bankruptcy Act jurisprudence, can require payment of contract rate interest in solvent debtor cases.”

    The Third Circuit stressed that the appropriate rate is actually the “equitable rate of post-petition interest, whatever that may be[,]” rather than the contract rate specifically. However, this is due to concerns that “paying one creditor contract rate interest might give it an inequitable leg up over its peers if there is not enough to pay everyone their full rate.” Here, with equity holders receiving $1.1 billion in value, there is no such concern. “It would be profoundly unfair to scrimp on the Noteholders’ interest when the junior Stockholders already received a billion dollar distribution.”

    Takeaways

    • The Third Circuit joined other courts, including the Fifth Circuit in Ultra Petroleum Corp. and the Ninth Circuit in Gas & Elec. Co., in finding that make-whole premiums constitute “unmatured interest” that is not allowable under Bankruptcy Code section 502(b)(2).
    • Hertz offers precedential support for the “solvent debtor exception,” allowing creditors of a solvent debtor to reclaim the full value of their claims.
    • Lenders to solvent debtors in the Third Circuit are likely to recover make-wholes even though lenders to insolvent debtors may not.
    • Creditors of solvent debtors are not guaranteed to receive post-petition interest at the contract rate. Rather, the appropriate post-petition rate of interest is subject to equitable considerations depending on the facts of the case.

    Authored by Douglas S. Mintz, Peter J. Amend and Matthew J. Hamparyan.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2024 Schulte Roth & Zabel LLP. All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors
    More insights

  • Texas AG’s Landmark AI Settlement: A Wake-Up Call for Health Tech & AI Companies

    Texas AG’s Landmark AI Settlement: A Wake-Up Call for Health Tech & AI Companies

    ARTICLE / CLIENT ALERT

    Texas AG’s Landmark AI Settlement: A Wake-Up Call for Health Tech & AI Companies

    September 27, 2024

    Read time: 2 min

    Key takeaways
    Overview

    The Texas Attorney General (AG) recently announced a “first-of-its-kind” settlement with a healthcare generative artificial intelligence (AI) company, Pieces Technologies, Inc., resolving allegations that the company made a series of false and misleading statements about the accuracy and safety of its AI products. The settlement highlights the potential for enforcement against AI companies under existing laws that are not specific to AI, and the importance of exercising caution in developing claims about an AI product’s efficacy or performance.

    In depth

    According to the Texas AG, at least four major Texas hospitals used Pieces’ generative AI products for purposes of producing clinical summaries and documentation from patient data. The settlement alleges that the company developed a series of metrics to claim that its healthcare AI products were “highly accurate,” including advertising and marketing the accuracy of such products and services by claiming “critical hallucination rate” and “severe hallucination rate” of “<.001%” and “<1 per 100,000,” respectively. The Texas AG alleged that “these metrics were likely inaccurate and may have deceived hospitals about the accuracy and safety of the Company’s products,” in violation of the Texas Deceptive Trade Practices – Consumer Protection Act.

    While the settlement did not impose any financial penalties, it requires the company to comply with a variety of provisions designed to ensure clear and conspicuous disclosures regarding AI tool performance, including:

    • Marketing and advertising disclosures – For any marketing or advertising that includes direct or indirect statements regarding any metrics, benchmarks, or similar measurements describing the outputs of its generative AI products, the company must clearly and conspicuously disclose (1) the meaning or definition of such metric, benchmark, or similar measurement, and (2) the method, procedure, or any other process used by the company, or on the company’s behalf, to calculate the metric, benchmark, or similar measurement. Alternatively, the company may retain an independent third-party auditor to assess the performance or characteristics of the company’s products and services, and have all marketing and advertising be consistent with the independent auditor’s findings.
    • Prohibitions against misrepresentations – The company may not make any false or misleading statements regarding its AI products.
    • Customer disclosures – The company must provide current and future customers with documentation that clearly and conspicuously discloses any known or reasonably known harmful or potentially harmful uses or misuses of its products and services. This documentation must, at a minimum, include the following information:
      • The type of data and/or models used to train the products and services.
      • A detailed explanation of the intended purpose and use of the products and services, as well as any training or documentation needed to facilitate proper use of the products and services.
      • Any known, or reasonably knowable, limitations of its products or services, including risks to patients and healthcare providers from the use of the product or service, such as the risk of physical or financial injury in connection with a product or service’s inaccurate output.
      • Any known, or reasonably knowable, misuses of a product or service that can increase the risk of inaccurate outputs or increase the risk of harm to individuals.
      • For each product or service, all other documentation reasonably necessary for a user to understand the nature and purpose of an output generated by a product or service, to monitor for patterns of inaccuracy, and to reasonably avoid misuse of the product or service.
    • Additional requirements – The company must notify its principals, officers, directors, employees with managerial responsibilities for the conduct covered by the settlement, agents and representatives who participate in conduct related to the settlement, and successors of the company about the settlement, and must submit to compliance monitoring.

    The settlement requires the company’s compliance for five years, although the company may request that the settlement be modified at any time and/or rescinded after one year based on the company’s compliance, changes in the state or federal regulatory landscape, or changes or developments in generative AI technology and related industry standards, metrics, benchmarks, or similar measurements describing the outputs of generative AI products.

    As part of the settlement announcement, Texas AG Ken Paxton emphasized the importance of transparency from AI companies, particularly those operating in the healthcare space. “AI companies offering products used in high-risk settings owe it to the public and to their clients to be transparent about their risks, limitations, and appropriate use,” he stated. “Anything short of that is irresponsible and unnecessarily puts Texans’ safety at risk. Hospitals and other healthcare entities must consider whether AI products are appropriate and train their employees accordingly.”

    Key Takeaways

    The Texas AG settlement is likely the first of many enforcement actions by state regulators and other authorities against AI developers. The settlement illustrates the existing enforcement tools that regulators have available to take action against what they perceive to be bad actors. The customer disclosures that the settlement requires also may be a preview of the kinds of information that future state or federal AI legislation may require AI developers to provide to deployers or other affected stakeholders (and as reflected in the Colorado Artificial Intelligence Act that was enacted in May 2024). The settlement emphasizes the key legislative and regulatory priorities of transparency, accuracy, and consumer protection in AI development and marketing.

    The remediation steps imposed by the Texas AG serve as the starting point for preventative best practices that AI companies can adopt. AI compliance programs should include testing and documentation along these lines. The settlement also suggests that investing in consumer-facing, easy-to-understand explanations about the AI will be important, akin to how some companies have created “privacy centers” on their websites that go beyond the more formal language in their privacy policies and terms of use in order to earn public confidence in their privacy claims and protections.

    At the federal level, the Federal Trade Commission (FTC) has been active in using its consumer protection authority to oversee AI technologies. And the FTC has broad authority to seek enforcement against claims it finds to be unfair and deceptive – AI or otherwise. For example, the FTC has warned that companies may violate the FTC Act by making false or unsubstituted claims about an AI product’s efficacy, or by making retroactive changes to terms of service or privacy policies to adopt more permissive data practices (e.g., to start sharing consumers’ data with third parties or using that data for AI training). Companies should carefully scrutinize public-facing comments and claims regarding their AI capabilities even absent specific FTC rules for AI. Other federal regulators also have begun to increase their oversight of AI.

    While the focus of the Texas enforcement in this case was on an AI developer, AG Paxton’s statements emphasize that there is scrutiny on both developers and procurers of AI, including providers, payors, and other healthcare organizations. Healthcare stakeholders should prioritize the implementation of an AI governance framework that includes carefully evaluating and ensuring the substantiation of claims regarding the accuracy and safety of AI tools that they are developing, commercializing, procuring, or deploying.

    Our cross-practice team continues to closely monitor developments in AI; visit McDermott’s AI in Healthcare Resource Center to learn more. Reach out to one of the authors of this On the Subject or your regular McDermott lawyer to discuss the potential legal implications for your business.

    Authors

    Jiayan Chen

    Partner

    Washington, DC

    Jennifer S. Geetter

    Partner

    Washington, DC

    Shawn C. Helms

    Partner

    Dallas

    Grayson I. Dimick

    Associate

    Washington, DC

    More insights

  • OIG Recommends Additional Oversight of Remote Monitoring Services

    OIG Recommends Additional Oversight of Remote Monitoring Services

    ARTICLE / CLIENT ALERT

    OIG Recommends Additional Oversight of Remote Monitoring Services

    September 26, 2024

    Read time: 10 min

    Key takeaways
    Overview

    On September 24, 2024, the Office of Inspector General (OIG) at the US Department of Health and Human Services issued a report recommending additional oversight of remote physiologic monitoring (RPM) services furnished to Medicare beneficiaries. Read the full report, “Additional Oversight of Remote Patient Monitoring in Medicare Is Needed.”

    Many of the issues highlighted by OIG are inherent to the current RPM codes established by the American Medical Association (AMA) but may not actually be problematic. Other issues underscore the lack of information the Centers for Medicare & Medicaid Services (CMS) has about the types of health data being monitored and the devices used to provide remote patient monitoring services. Stakeholders should review their current remote monitoring programs to ensure that RPM services are being provided consistent with existing CMS regulations and should be on the lookout for additional potential changes to the requirements for RPM services.

    In depth

    Background

    Remote Monitoring Background

    In 2019, CMS expanded payment for remote monitoring services, which generally use digital technologies (i.e., medical devices, together with software) to collect medical and other forms of health data from patients in one location and electronically transmit the data to the patient’s healthcare provider in a different location for assessment and care management. The data collected is automatically electronically transmitted to health professionals for review and can be used in patient management. In some cases, the technologies can either trigger direct patient engagement or facilitate communication between the patient and health professional.

    RPM services involve monitoring physiological metrics or parameters (e.g., weight, blood pressure, blood sugar) through medical devices that transmit data obtained from patients automatically to healthcare providers for assessment and recommendations. In contrast to RPM services, remote therapeutic monitoring (RTM) services involve the use of medical devices to monitor a patient’s health or response to treatment using non-physiological data. RTM can be used to monitor medication adherence, response to therapy, musculoskeletal activity, and respiratory activity.

    RPM services include the following five CPT codes, which CMS contemplates together comprise the three basic components of RPM services:

    CPT Code RPM Service Type Code Description
    99453 Patient Education and Device Set-Up Remote monitoring of physiologic parameter(s) (e.g., weight, blood pressure, pulse oximetry, respiratory flow rate), initial; set-up and patient education on use of equipment
    99454 Device Supply Remote monitoring of physiologic parameter(s) (e.g., weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days
    99091 Treatment Management Services Collection and interpretation of physiologic data (e.g., ECG, blood pressure, glucose monitoring) digitally stored and/or transmitted by the patient and/or caregiver to the physician or other qualified health care professional, qualified by education, training, licensure/regulation (when applicable) requiring a minimum of 30 minutes of time, each 30 days
    99457 Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes
    99458 Each additional 20 minutes (list separately in addition to code for primary procedure)

    Not surprisingly, the availability of Medicare reimbursement for remote monitoring services has led to substantial interest in furnishing such services, because Medicare is a major payor for healthcare items and services in the United States.

    Prior OIG Alerts

    In November 2023, OIG issued a consumer alert focused on remote patient monitoring, particularly direct-to-consumer RPM programs that involve the use of advertising (through phone, television, or internet-based marketing) directed towards Medicare beneficiaries. This alert was intended to alert Medicare beneficiaries to the potential for fraud schemes involving bad actors that sign patients up for remote monitoring without an established provider-patient relationship. Of note, the alert mentioned remote monitoring furnished by a durable medical equipment company or pharmacy. The alert recommended that consumers report companies offering unsolicited medical equipment to the OIG hotline. OIG also noted the risks associated with companies “cold calling” Medicare beneficiaries to solicit them to receive remote monitoring services.

    Key Takeaways

    OIG conducted a data-driven analysis of Medicare and Medicare Advantage claims and encounter data. OIG reviewed claims for RPM services furnished between January 1, 2019, and December 31, 2022. This report did not include a review or analysis of RTM services. OIG expressed concern that Medicare lacks certain key information regarding remote patient monitoring. Specifically, OIG asserted that CMS does not have information about the types of health data being collected or information about the types of devices that are being used. Providers are not currently required to report this information, and there is no readily available way for providers to report this information. Similarly, providers are not obligated to report the ordering provider on claims for RPM services.

    OIG highlighted the increase in utilization of RPM services between 2019 and 2022. Medicare and Medicare Advantage payments for RPM services totaled more than $300 million in 2022, compared to $15 million in 2019. OIG noted that the increase in payments was due not only to an increase in patients who received services, but also to an increase in the length of time that patients received RPM services. In 2022, patients received RPM services for an average of five months, compared to an average of three months in 2019. There are currently no Medicare national or local coverage determinations limiting the amount of time that a patient may receive remote monitoring services. As OIG noted, the majority of RPM services are furnished to patients with chronic conditions (which by definition tend to last for 12 months or more), and RPM services can serve as a useful tool to manage these conditions.

    CMS established payment rates for RPM services in 2019 and provided guidance on certain requirements for and appropriate utilization of remote monitoring services. In response to the COVID-19 public health emergency, CMS also issued several waivers and flexibilities that were explicitly intended to expand providers’ ability to furnish remote monitoring services to patients, including flexibilities regarding who could furnish the services, the types of technology that could be used, and how many days of monitoring were required to be obtained in order to bill. While OIG’s report focused on the increase in utilization of RPM services, much of this increase can simply be attributed to the fact that prior to 2019, Medicare and Medicare Advantage did not provide payment for the majority of the RPM CPT codes. Indeed, the majority of the RPM CPT codes did not exist before 2019.

    OIG highlighted that 43% of patients did not receive all three components of RPM services – patient education and device set-up, device supply, and treatment management services. While CMS has suggested that each component of RPM builds on the other, there is no explicit requirement that a provider must furnish all of the RPM services covered by all of the RPM CPT codes to receive payment for any services. To the contrary, specific requirements must be met in order for providers to bill for certain RPM codes. For example, both the patient education and the device supply codes currently only can be reported when a provider collects 16 days’ worth of data from a patient. If these code requirements are not met, it would be improper for a provider to bill for these services. CMS also has previously clarified that the treatment management services can be provided even where the data collection requirements for the device supply code are not satisfied.

    OIG also expressed concern that 12% of patients did not receive treatment management services at all, which OIG concluded may indicate that patients did not receive the full benefit of RPM services or that the monitoring services may not have been necessary for the patient. The treatment management codes for RPM services require that the provider furnish at least 20 minutes of treatment management services. It is entirely possible that a provider furnishes treatment management services to a patient but does not meet the time-based thresholds for billing for the treatment management services. For example, a provider who furnishes 14 minutes of treatment services would be unable to bill for a treatment management code. The treatment management services also require a real-time, interactive communication with the patient. Many providers communicate with patients via text message; without a phone call or another live interaction with the patient, the provider will not be able to bill.

    OIG ultimately recommended that CMS take the following steps to improve oversight of RPM services:

    1. Implement additional safeguards to ensure that remote patient monitoring is used and billed appropriately in Medicare.
    2. Require that remote patient monitoring be ordered and that information about the ordering provider be included on claims and encounter data for remote patient monitoring.
    3. Develop methods to identify what health data are being monitored.
    4. Conduct provider education about billing of remote patient monitoring.
    5. Identify and monitor companies that bill for remote patient monitoring.

    Practical Impact

    Many of the concerns highlighted by OIG are inherent within the current AMA-established CPT codes for RPM services. This includes the requirement to obtain 16 days’ worth of data from a patient in order to bill for the CPT codes corresponding to patient education and the RPM device supply. The AMA recently considered changes to the RPM codes that may address some of these issues. If these code changes are finalized, CMS will have an opportunity to provide additional guidance that could assuage some of the concerns raised by OIG. Alternatively, CMS could choose to establish its own set of HCPCS codes for RPM services, but this would effectively establish two parallel set of codes and likely would be unduly burdensome for providers.

    OIG issued specific recommendations for CMS that are intended to improve oversight of remote patient monitoring services. Most of these recommendations would require CMS to establish new or modified regulations. Any regulatory changes would require notice-and-comment rulemaking. Accordingly, companies should carefully review CMS’s annual rulemaking and ensure that comments and feedback to proposed changes are submitted for consideration.

    Certain of OIG’s statements in the report are not entirely consistent with prior CMS and Medicare Administrative Contractor guidance on RPM services. Although there may be opportunities for CMS to provide additional clarity through changes to regulations, certain OIG suggestions – in particular, the requirement for an order for RPM services – have previously been addressed by CMS in guidance.

    Finally, both providers that furnish RPM or RTM services and digital health companies that help providers furnish these services should continue to monitor OIG and CMS publications on RPM services. While OIG’s report was specifically focused on RPM services, certain issues highlighted may also be relevant to RTM services. More importantly, companies should ensure that their remote monitoring programs (including policies, procedures, and general practices) are consistent with existing CMS regulations and structured to address the concerns highlighted by OIG, if and as appropriate. In light of the increasing scrutiny of remote monitoring services, companies should ensure that their compliance programs fully address the unique risks and considerations presented by these services.

    OIG noted that additional work is being performed to examine remote patient monitoring, and that remote patient monitoring remains on the OIG work plan. Stakeholders should be aware that this report may prompt CMS to implement additional measures to ensure that remote monitoring services are furnished consistent with existing requirements and guidance or could prompt CMS to impose additional limitations or requirements on RPM and/or RTM services.

    Authors

    Caroline Reignley

    Partner

    Washington, DC

    Marshall E. Jackson , Jr.

    Partner

    Washington, DC

    James A. Cannatti III

    Partner

    Washington, DC

    Lisa Mazur

    Partner

    Chicago

    More insights

  • Contract manufacturing versus an alternating proprietorship: What is the difference?

    Contract manufacturing versus an alternating proprietorship: What is the difference?

    ARTICLE

    Contract manufacturing versus an alternating proprietorship: What is the difference?

    Sep 26, 2024

    Read time: 5 min

    Key takeaways
    Overview

    We frequently receive questions about the differences between contract brewing and alternating proprietorships, as well as questions concerning the key details the Alcohol and Tobacco Tax and Trade Bureau (TTB) and other regulators will be looking for in either approving the proposed structure or, more importantly, during a company audit. Here we discuss the primary considerations for businesses utilizing other premises for production.

    Alternating Proprietorship. The TTB allows two or more proprietors with different federal employer identification numbers (FEINs) to operate their respective businesses at the same premises by alternating and sharing space and/or equipment. How does it work? Typically, each proprietor obtains its own federal and state licenses and permits and operates and produces on its own behalf; these latter tasks include maintaining its own reports, records, excise tax payments, label approvals, and bond changes once approved. One proprietor is the “host,” and another is a “tenant” paying rent to the host. The rent can be a fixed monthly rate or based on equipment-hour usage. Other shared-cost arrangements are possible, as well.

    During its review of an alternating proprietor’s application for a federal basic permit, the TTB will evaluate the written agreement between the alternating proprietor and the host. The TTB’s primary concern is to ensure the protection of each proprietor’s revenue. As such, the separation and movement of each proprietor’s products, payment of taxes, etc., will likely face the most scrutiny by TTB in an alternating proprietorship agreement. Accordingly, the alternating proprietorship agreement should expressly state that the alternating proprietor is responsible for its own production, recordkeeping, reporting, labeling, and payment of taxes. The agreement should provide that the alternating proprietor will pay the host directly for its floor space, equipment use, and, where applicable, personnel time and material consumed if the host is to provide additional services or materials. Payment to the host should not be based on volume rates (e.g., tons, gallons, or cases). The TTB reviews all of these factors to determine if the arrangement is a true alternating proprietorship and not a contract manufacturing relationship in disguise.

    Entities engaging in alternating proprietorships frequently use a combination of direct employees and independent contractors to maintain their operations. In this highly specialized industry, independent contractors are in high demand due to their extensive knowledge and experience. Utilizing these workers enables producers to meet higher production targets with a shorter learning curve, while allowing direct employees to learn the process with limited downtime. However, it should be clear in the alternating proprietorship agreement that these employees are acting solely at the alternating proprietor’s direction, or they should be hired directly by the alternating proprietor.

    Contract Manufacturing. Also known as co-packing, contract manufacturing is an operational methodology that differs from an alternating proprietorship. With contract packaging, a co-packer entity produces and/or packages product(s) on behalf of their customers, with all operations occurring under the co-packer’s license or permit and often under the customer’s trade name. In a co-packing situation, the co-packer also may be producing or packaging for multiple customers at the same time. Since these operations all occur under the co-packer’s permit, the co-packer handles all related reporting, records management, tax payments, and label approvals. From an excise tax perspective, this type of operation generally results in the application of the TTB’s single-taxpayer rule, which aggregates all production of the co-packer, regardless of the number of customers, for purposes of eligibility for reduced excise tax rates under the Craft Beverage Modernization Act. For this reason –  and to avoid excessive tax liability in future audits for both the co-packer and its customers – it is imperative to understand these implications.

    Key Considerations. When assessing whether to engage with a third party under an alternating proprietorship or contract manufacturing arrangement, it is important to keep in mind the key differences between these two options. These methods of operation are quite distinct: An alternating proprietorship is made up of multiple separate permittees sharing space and/or equipment and operating on their own behalf with only one entity operating in the alternating areas at any given time, whereas co-packing is a single entity operating on behalf of other entities, with operations able to occur simultaneously throughout the premises since the premises are controlled by a single permittee. For this reason, the TTB will thoroughly analyze each of these operations during the audit process, from ingredient acquisition and production to sales and recordkeeping, to assure that the operations and ways of working do in fact mirror the chosen model.

    In conclusion, there are advantages and disadvantages to the contract manufacturing arrangement and alternating proprietorship arrangement. Industry members, new and seasoned, must carefully consider a number of factors before deciding which structure to use. This can be a complex and confusing process; if you are interested in learning more, contact one of the members of McDermott’s alcohol beverage team.

    Authors

    Alva C. Mather

    Partner

    Washington, DC

    Christine Dower

    Counsel

    Washington, DC

    Michelle L. Draper

    Senior Alcohol Regulatory Specialist

    Wilmington

    More insights
    Endnotes

  • Legal Lens on the Unified Patent Court | September 2024

    Legal Lens on the Unified Patent Court | September 2024

    ARTICLE

    Legal Lens on the Unified Patent Court | September 2024

    September 2024

    Read time: 2 min

    Key takeaways
    Overview

    The Unified Patent Court (UPC) is revolutionizing the way patents are enforced in Europe, and McDermott’s intellectual property team is here to help you navigate this dynamic landscape. Our Legal Lens on the Unified Patent Court newsletter is designed to keep patent holders and legal departments well-informed. And with an on-the-ground team in Germany, France, the United Kingdom and the United States, we offer a unique cross-border perspective.


    In depth
    Authors

    Diana Pisani

    European Patent Attorney

    London – 22 Bishopsgate

    Keval Amin

    Associate

    Chicago

    Aashish Kapadia

    Partner

    Austin

    More insights

  • DOJ Makes Key Revisions to Corporate Compliance Program Guidance

    DOJ Makes Key Revisions to Corporate Compliance Program Guidance

    ARTICLE / CLIENT ALERT

    DOJ Makes Key Revisions to Corporate Compliance Program Guidance

    September 25, 2024

    Read time: 7 min

    Key takeaways
    Overview

    On September 23, 2024, the US Department of Justice (DOJ) updated its Evaluation of Corporate Compliance Programs guidance (ECCP). Changes to the ECCP build on themes that the DOJ has been emphasizing for some time, including risk assessment, compliance empowerment, effective reporting structures, and continuous improvement. The most recent updates encourage companies to:

    • Manage evolving risks associated with technology, including artificial intelligence (AI);
    • Empower compliance with data and resources;
    • Ensure the organization has a speak-up culture and whistleblower protections; and
    • Learn from others, reevaluate risks, and make compliance enhancements.
    In depth

    What’s New

    Managing Evolving Risks Associated With Technology, Including AI

    The DOJ has long expected companies to review and update their compliance programs to account for emerging risks. With this latest version of the ECCP, the department expands this concept to risks associated with the use of new and emerging technologies, including AI. The revised guidance instructs prosecutors to scrutinize how companies use AI, assess related risks, and take proactive measures to prevent AI-enabled criminal schemes.

    What type of compliance risks might companies encounter when using AI and other emerging technologies? In recent remarks, Principal Deputy Assistant Attorney General Nicole M. Argentieri suggested that “false approvals and documentation generated by AI” could be used to facilitate criminal activity. Companies also risk relying on inaccurate data leveraged from untested or unreliable technologies. To protect against such risks, the DOJ expects companies to:

    • Assess and mitigate risks associated with the use of new or emerging technologies, including AI;
    • Develop and implement a governance strategy regarding the use of new technologies;
    • Implement controls to monitor and ensure that AI and similar technologies are being used for their intended purpose in compliance with applicable laws and the company’s code of conduct, and to confirm the accuracy and reliability of the data leveraged from such technologies;
    • Consider an appropriate baseline of human decision-making when using AI; and
    • Train employees on the use of AI and other emerging technologies.

    While the DOJ intensifies its focus on AI, companies should consider these updates to the ECCP when implementing any novel technology solution for business or compliance purposes. This is particularly important given that the DOJ has increasingly encouraged companies to leverage data and technology in their compliance programs, as discussed below.

    Empowering Compliance With Data and Resources

    The DOJ views data as a powerful tool to prevent and detect misconduct. Prior versions of the ECCP encouraged the use of data to monitor and test policies, controls, and transactions. The revised ECCP heightens this focus, asking:

    • Whether compliance personnel have timely access to relevant data sources;
    • Whether the company is leveraging data analytics to create efficiencies in compliance operations and measure compliance program effectiveness; and
    • How the company is managing data quality and measuring the accuracy, precision, and recall of data analytics models.

    Data is critical to facilitating testing of the compliance program, which is another focus area of the revised ECCP. For instance, the updated guidance suggests that companies should:

    • Confirm that employees know how to access relevant policies (which may involve tracking policy access or testing knowledge through surveys or other means);
    • Evaluate employees’ engagement with training content (which may involve collecting data on completion rates and comprehension);
    • Leverage data to evaluate third-party risk during the relationship; and
    • Take steps to measure the success and effectiveness of their compliance programs.

    The revised ECCP also newly emphasizes “proportionate resource allocation,” which suggests that companies should empower compliance and risk management functions with the same level of technology and resources available to commercial teams.

    Protecting Whistleblowers and Promoting a Speak-Up Culture

    Whistleblowers are having more than a moment. Companies have raced to amend policies and procedures as the patchwork of European whistleblower laws grows and evolves in the wake of the European Union Whistleblower Directive. On this side of the pond, US government agencies continue to have success with whistleblower programs. In 2023 alone, the Securities and Exchange Commission’s whistleblower program generated more than 18,000 whistleblower tips and nearly $600 million in awards. It is, therefore, no surprise that the DOJ implemented its own Corporate Whistleblower Awards Pilot Program earlier this year to incentivize information sharing with the department. Despite being in place for less than a month, the program has already garnered tips from over 100 individuals.

    Against this backdrop, the revised ECCP includes a new section titled “Commitment to Whistleblower Protection and Anti-Retaliation,” which reinforces the need to invest in a speak-up culture. Receiving internal reports of potential misconduct enables companies to investigate and stop misconduct, consider disclosure, and make compliance program enhancements. To facilitate reports, companies must establish internal reporting channels and an anti-retaliation policy. Training on internal reporting options and requirements is paramount. The revised ECCP goes further, asking:

    • Whether companies are training not just on internal reporting avenues but also on external whistleblower protection laws, whistleblower programs, and regulatory regimes;
    • Whether companies’ practices “tend to chill” reporting;
    • Whether employees involved in misconduct are treated differently based on whether they internally reported misconduct;
    • How companies “assess employees’ willingness to report misconduct”; and
    • Whether companies “incentivize reporting of potential misconduct.”

    Companies should think creatively about internal reporting. If you review any company’s code of conduct, you will likely encounter a section requiring employees to report potential violations of the law, code, or policy. The DOJ’s recent updates to the ECCP call for companies to go even further.

    Taking a Broad View of Lessons Learned

    Companies must learn from both their own issues and those of others. The DOJ’s updates to the ECCP illustrate that companies cannot afford to have tunnel vision when determining their risk profile. Both internal and external circumstances should inform compliance programs. The revised ECCP emphasizes the importance of considering lessons learned by “other companies operating in the same industry and/or geographic region” when conducting risk assessments, designing and updating policies and procedures, and delivering tailored training.

    Other Updates

    • Post-M&A integration: Compliance and risk management personnel should be involved in post-transaction integration planning. The revised ECCP asks, “Does the company account for migrating or combining critical enterprise source planning systems as part of the integration process?”
    • Third-party management: The revised ECCP instructs prosecutors to consider whether a company’s third-party management process allows for the review of vendors in a timely manner, emphasizing the need for efficiency in the process.
    • Training and communications: Echoing existing guidance, the revised ECCP emphasizes that training and communications should be tailored to the particular needs, interests, and values of relevant employees.

    Looking Ahead

    Now is the time to review your corporate compliance program. Consider whether your risk assessment methodology addresses the DOJ’s focus areas. Assess whether there are opportunities to make enhancements to your corporate compliance program to navigate emerging technology, access to data, whistleblowers, and industry risks. McDermott’s white-collar and securities defense team can identify practical ways to strengthen your compliance program in line with evolving government expectations.

    Authors

    William W. Hameline

    Associate

    Chicago

    More insights

  • The UK Court of Appeal Rules on the Interpretation of “Frankenstein” Contracts

    The UK Court of Appeal Rules on the Interpretation of “Frankenstein” Contracts

    ARTICLE / CLIENT ALERT

    The UK Court of Appeal Rules on the Interpretation of “Frankenstein” Contracts

    September 26, 2024

    Read time: 10 min

    Key takeaways
    Overview

    Lenders and contract drafters will welcome the 18 June 2024 UK Court of Appeal ruling in Yieldpoint vs Kimura1, which overturned a controversial High Court ruling in which the grantor of a participation in a loan was ordered to repay a participant’s capital on default of the underlying borrower. The initial ruling concluded that the inclusion of specific contractual terms and conditions (dubbed the “Frankenstein Slip”)2 was sufficient to convert the original sub-participation agreement to an unsecured fixed-term loan, repayable by the lender irrespective of whether the underlying borrower defaulted.

    The case required complex analysis of the terms of the participation agreement and overarching umbrella agreement, but the Court of Appeal ultimately concluded that the High Court had adopted the incorrect approach in completing its interpretation. The Court of Appeal stated that greater focus should have been given to reading the provisions of the agreement together, and some consideration needed to be given to the commercial sense of the agreement. As such, the High Court decision was reversed, and the participant’s investment was lost.

    In depth

    Overview of a Participation

    Although a sub-participation is a relatively common financial transaction, it has no strict legal meaning in English law. A sub-participation (also known as a participation) is an alternative to a novation and an assignment, enabling a lender to transfer its economic risk in a loan to another party whilst remaining the lender of record. It does not involve the legal transfer of the underlying loan itself, which would require the borrower to agree to the loan being transferred. Instead, a sub-participation creates a new arrangement between the lender of record and the new party (the participant) that is separate to, and distinct from, the underlying loan. The participant, in return for a payment to the lender of record for a share of their loan, receives a share of the interest paid to the lender of record, whilst simultaneously taking on the borrowers’ risk of default for the share of the loan they have taken on.

    Background

    On 10 December 2019, Kimura Commodity Trade Finance Fund Limited (Kimura) entered into a loan facility (the Facility) extended to Chilean mining company, Minera Tre Valles SPA (MTV). Kimura held 50% of this facility alongside another party, which was fully funded at all times. Subsequent to this, Kimura agreed a Master Participation Agreement for Trade Transactions (the MPA) with Yieldpoint Stable Value Fund LP (Yieldpoint) on 19 February 2021, pursuant to a sub-participation agreement was drafted which allowed Yieldpoint to participate in Kimura’s share of the Facility (the MTV Participation). Yieldpoint paid Kimura US$5million in exchange for a share of (a) the quarterly interest rate of the Facility set at 3-month LIBOR plus 7.5% (0.5% less than Kimura’s entitlement under the Facility); and (b) a pro-rata share of Kimura’s monthly price participation entitlement under the Facility (based on the price of copper). The MPA, and therefore the MTV Participation, proffered by Kimura, were based on the standard form, at the time, made available by the Bankers Association for Finance and Trade, but was slightly amended to include a “Maturity Date of the Participation” dated 31 March 2022 and a special condition providing for Yieldpoint to give 45 days prior notice if it intended to renew its participation.

    The Issue

    Traditionally, the concept of a maturity date within a participation agreement is “alien” and, due to its general use in referring to the end of a loan period, is in conflict with the essence of a participation agreement. This formed the basis of this dispute and was the issue that received significant attention from the court.

    MTV ceased its operations in January 2022 and by 31 March 2022, MTV had defaulted on its payment obligations under the Facility. The company was later declared bankrupt by the Civil Court of Santiago in February 2023.

    Yieldpoint provided notice of its intention not to renew its participation in February 2022, as permitted under the MTV Participation agreement. However, Kimura did not repay the claimed US$5million of capital to Yieldpoint. The basis on which this was refused was that Yieldpoint had been exposed to the default risk (as is generally the case in a typical sub-participation) and was therefore not entitled to a repayment.

    Yieldpoint contested that the wording of the MPA and the MTV Participation agreement meant that the arrangement was more akin to an unsecured fixed-term loan, which, in the absence of a notification to extend, was repayable in full on 31 March 2022.

    The issue was first heard at the High Court, before going to the Court of Appeal.

    The High Court Decision

    The High Court carefully considered the wording of, and the interplay between, the MTV Participation agreement and the MPA. It found that irrespective of the arguments made by either side, that the MTV Participation agreement was a “[…] mutant or variant, on any view […]”3 rendering parts of the MPA “otiose”4. On Yieldpoint’s analysis the court stated that Yieldpoint “[…] was not staking its capital in any meaningful sense. It was sharing primary default risk on and acquiring equitable recourse for the year’s rent for its money, but nothing else.”5 The court held that this interpretation turned “almost entirely upon the insertion of “Maturity Date of the Participation” by way of adaptation to the Template Offer and insertion of the Special Conditions relating to renewal upon notice.”6.

    The court went on to conclude that, despite the “difficulties”, the problems faced were “surmountable” but “not without some discomfort”7. The arguments made indicated that there was no common mistake in preparing and reaching the binding agreement, and the court’s task was to ascertain the meaning and effects of the agreement that was dubbed a “Frankenstein’s Slip”8. As such, Yieldpoint’s analysis was favoured, and the contract was held to be a hybrid agreement containing both a fixed term loan and a participation. Kimura was therefore liable in debt for US$5million plus interest.

    Kimura appealed this ruling to the Court of Appeal.

    The Court of Appeal Decision

    The Court of Appeal reversed the High Court decision and found in favour of Kimura. It held that the MTV Participation was in fact a conventional sub-participation. As a result of this conclusion and the fact that the company had defaulted prior to the maturity date, it was held that Yieldpoint was not entitled to be repaid its US$5million investment.

    In coming to this decision, the Court of Appeal agreed with the High Court in its assessment of the fact that the labelling of an agreement did not establish the legal rights and duties created by the drafting of the contract9. The decision did however come down to the construction of the agreement and was a question of law10, and the interpretation needed to follow the established principles in Rainy Sky SA v Kookmin Bank11 and Wood v Capita12 focussing, in particular, on:

    1. The application of an iterative process by which each suggested interpretation is checked against the provisions of the contract and its commercial consequences as a means of completing the contractual interpretation process.
    2. The admissibility of evidence that provided the factual background known to the parties at or before the genesis of the contract including the origins and objective aim of the transaction (noting that parties’ intentions and negotiations were inadmissible).

    In applying this process, the Court of Appeal concluded that the MTV Participation agreement only made sense if read together with the MPA which contained the express terms of the overarching transaction. With this in mind, the court considered it unlikely that the MTV Participation agreement, despite its amendments and special conditions, could not have represented anything other than a traditional sub-participation. If the intention had been for Yieldpoint to enter into a fixed term loan, the overarching terms of the MPA would have been abandoned.

    When considering the inclusion of the “Maturity Date of the Participation”, and whether this wording was sufficiently strong to depart from the MPA provisions and intentions, it held that the wording did not do enough to overturn the core provisions. Instead, the Court of Appeal held that this approach to interpretation was incorrect and that “The right approach was first to seek to read all the contractual provisions together, in order to reach a coherent interpretation of the entire contract which conforms with commercial sense.”13 The court added that it was only when this method was “not possible that it [was] necessary to determine which provisions should be given priority and which given a modified reading or overridden altogether.”14 With this in mind, the court concluded that “If that approach had been adopted in this case, it [was] difficult to see that the MTV Participation, in the context of the MPA, would be read as anything other than a conventional sub-participation agreement with early redemption.”15

    Finally, the court added that when considering the commercial sense of the MTV Participation agreement in the context of the competing interpretations, that the lower court was wrong to “discount the fact that Yieldpoint’s proposed interpretation was highly uncommercial”16 and that Kimura would likely not have “agreed to transfer most of its benefit from US$5m of its part of the Facility without Yieldpoint exposing its capital.”17 It was acknowledged that courts were generally wrong to consider whether the consideration given by one party to a contract was adequate or to consider the commercial motives, but that in this case it was a “strong factor”18, which, if applying Yieldpoint’s interpretation of the agreement, “undermine[d] the commercial sense of the structure set out in the MPA.”19

    As a result, the Court of Appeal found in favour of Kimura and allowed the appeal, and concluded that, Yieldpoint was not entitled to be repaid its US$5million investment on MTV’s default, and Yieldpoint was exposed to the underlying credit risk of the Borrower as would be the case in ordinary sub-participation agreements.

    Comment

    Lenders and contract drafters will welcome this decision, which restores the orthodox view that an agreement subject to an umbrella agreement should be read, first and foremost, in its entirety, whilst also considering the commercial sense and understanding of the proposed terms. This concern was well founded given the High Court judgment found that the inclusion of a single term was sufficient, albeit with “some discomfort”, to subvert the general terms of an agreement. While the reversal is welcomed, it poses the question of where the boundary lies for a court to hold that the changes to a sub-agreement are sufficient to alter the meaning of an umbrella agreement, enough to significantly alter the overall commercial intentions. From a commercial perspective, the decision of the Court of Appeal was a welcome one given the widespread use of sub-participation agreements by lenders in the credit market seeking to de-risk positions.

    The contrary decision at first instance also underlines the importance for contracts to address clearly each significant potential outcome. This was recognised by Lord Justice Philips in his comments that: “Parties discussing a trade often focus on what will occur if all goes to plan, without addressing what they no doubt consider to be the unlikely situation of default or non-performance, leaving that to the written terms”.20 Forethought and clear drafting are particularly crucial where there may be a significant transfer of wealth from one party to another if a relevant event has occurred, and which, as a result, could well become contentious.

    *Nicholas Hunt (trainee) contributed to this article.

    Authors

    Harry Denlegh-Maxwell

    Senior Associate

    London – 22 Bishopsgate

    More insights

  • CFTC Increases Financial Thresholds for Qualified Eligible Person Status

    CFTC Increases Financial Thresholds for Qualified Eligible Person Status

    ARTICLE / CLIENT ALERT

    CFTC Increases Financial Thresholds for Qualified Eligible Person Status

    September 18, 2024

    Read time: 8 min

    Key takeaways
    Overview

    On Sept. 12, 2024, the Commodity Futures Trading Commission (“CFTC”) adopted amendments (“Final Rule”)[1] to CFTC Rule 4.7, which is the primary disclosure, reporting and recordkeeping relief relied upon by CFTC-registered commodity pool operators (“CPOs”) and commodity trading advisors (“CTAs”). The Final Rule only partially adopted the proposals advanced by the CFTC nearly a year ago (“Proposal”). Importantly, the CFTC has elected to double the financial thresholds required for investors to be Qualified Eligible Persons (“QEPs”) suitable to invest in a Rule 4.7 pool or fund. However, the CFTC decided not to adopt the time-consuming and detailed disclosure requirements included in the Proposal. Operators of Section 3(c)(1) pools and funds that rely on Rule 4.7 will need to adjust their documents to accommodate the new QEP financial thresholds. We do not anticipate any substantive impact on operators of Section 3(c)(7) pools and funds.

    Background

    Almost one year ago[2], the CFTC proposed amendments to Rule 4.7 that, along with relatively minor technical changes, would have required vehicles and accounts relying on Rule 4.7 relief to provide extensive investor disclosures (including break-even fee and expense analysis per unit of participation, and historical performance), as well as doubled the thresholds of the financial test that must be met for certain persons to qualify as eligible participants in Rule 4.7 funds and accounts (“Portfolio Requirement”). As Rule 4.7 currently does not require delivery of a disclosure document at all, and several of the proposed disclosures were unlikely to be included in managers’ existing documents, the disclosure changes attracted particular attention from commenters (eight comment letters were received in total, including letters from the National Futures Association, SIFMA AMG and the Managed Funds Association, all of which advised against adopting the Proposal’s mandatory disclosure requirements).

    The Final Rule does not include the extensive mandatory disclosures included in the Proposal; although the CFTC has noted that it may revisit such changes in the future. The CFTC has, however, adopted its proposed amendments to the QEP Portfolio Requirement, along with codifying certain existing no action relief for account statement delivery and making minor “housekeeping” edits to Rule 4.7 to update rule cross-references. The Final Rule will be effective 60 days after publication in the Federal Register and the compliance date for the new Portfolio Requirement will be six months after publication.

    Changes to the Portfolio Requirement

    Updates to QEP Standard — Inflation Adjustment Increases to Portfolio Requirement Thresholds

    The Final Rule adopts the CFTC’s revised Portfolio Requirement as proposed, while clarifying the implementation period for these new thresholds. Note that not all investors in Rule 4.7 pools and funds will be affected by the revised Portfolio Requirement. QEPs fall into two categories: (i) those subject to a Portfolio Requirement as outlined in paragraphs (a)(1)(v) and (c)(3) of Rule 4.7 itself, and (ii) those exempt from complying with this test in view of some other status (most importantly, non-US Persons and Qualified Purchasers). This latter category of investors remains unchanged by the Final Rule. However, once effective, the revised Portfolio Requirement will double the financial thresholds for subject investors:

     

    Current Thresholds

    Amended QEP Thresholds

    Asset Threshold: owning securities and other assets of the stipulated value.

    $2 million

    $4 million

    Deposit Threshold: having on deposit with a futures commission merchant for their
    own account at least the stipulated amount in initial margin, option premiums or minimum
    security deposits.

    $200,000

    $400,000

    As under the current definition, an investor may also satisfy the Portfolio Requirement by owning a portfolio of funds and assets that, when expressed as percentages of the prior two thresholds, have a combined value of at least 100 percent.

    Effect of the Revised Portfolio Requirement

    Aside from potential pro forma amendments to their subscription documents, managers who operate Section 3(c)(7) funds[3] relying on CFTC Rule 4.7 will not be affected by the revised Portfolio Requirement. These funds collect Qualified Purchaser representations from their ordinary investors, and knowledgeable employees — a potential category of 3(c)(7) investor exempt from the Qualified Purchaser requirement under Rule 3c-5 — are also a category of QEP that is exempt from compliance with the Portfolio Requirement. Similarly, operators of Rule 4.13(a)(3) funds (whether relying on Section 3(c)(7) or 3(c)(1) SEC relief) are unlikely to be substantively affected by the new QEP thresholds, as the Rule 4.13(a)(3) exemption is satisfied by the Accredited Investor thresholds which are lower than those for the QEP definition.[4]

    Managers of Rule 4.7 Section 3(c)(1)[5] vehicles will, however, need to adjust their offering documents to accommodate the revised Portfolio Requirement. As noted, the revised Portfolio Requirement will be effective six months after the Final Rule is published in the Federal Register. After that time, the CFTC has confirmed that managers of Section 3(c)(1) funds or accounts will not be required to redeem or terminate an advisory relationship with an existing investor that is unable to meet the new Portfolio Requirement. However, all future investments (including by existing investors) must occur in compliance with the new Portfolio Requirement once it is effective.

    Other Changes

    Codifying existing no action relief, the Final Rule also amends Rule 4.7 to explicitly permit funds of funds to choose an alternate monthly schedule for delivery of attested account statements. Under the current Rule, attested account statements must be provided to investors within no less frequently than quarterly, within 30 days of quarter end. As amended, Rule 4.7 permits managers of funds of funds to instead deliver these reports on a monthly basis within 45 days of month end, provided that the account statements otherwise meet all of the requirements of Rule 4.7 and investors are informed about the alternate distribution schedule either in fund’s private placement memorandum delivered prior to an initial investment, or upon adoption of the alternate reporting schedule, for existing investors. This new mechanic will be available to Rule 4.7-compliant funds of funds once the Final Rule is effective; compliance with its terms is required upon election of the new schedule. Unlike the prior no action relief this amendment replaces, special notice to the CFTC is not required under this new provision.

    Key Action Steps

    Managers of Section 3(c)(1) vehicles relying on Rule 4.7 will need to ensure that they are prepared to 1) make necessary amendments to their subscription documents reflecting the revised QEP Portfolio Requirement and 2) collect updated QEP representations for any future investments subject to the revised Portfolio Requirement. It may be advisable to collect updated investor representations well in advance of the six-month effective date of the revised Portfolio Requirement. Managers of 3(c)(7) and other funds may wish to review their subscription documents for any necessary pro forma amendments.

    Authored by Daniel F. Hunter and Joshua B. Wright.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] See Commodity Pool Operators, Commodity Trading Advisors and Commodity Pools Operated under Regulation 4.7: Updating the ‘Qualified Eligible Person’ Definition; Adding Minimum Disclosure Requirements for Pools and Trading Programs; Permitting Monthly Account Statements for Funds of Funds; Technical Amendments (Pre-Print).

    [2] See Schulte Alert: CFTC Proposes Rule 4.7 Changes That Would Impose Significant New Disclosure Requirements for Many CPO-Registered Fund Managers and CTA-Registered Advisers, accessible here.

    [3] A Section 3(c)(7) fund is a pooled investment vehicle that is excluded from the definition of investment company in the Investment Company Act because it is limited to investors that are Qualified Purchasers and otherwise meets criteria outlined in Section 3(c)(7) of the Investment Company Act.

    [4] The Accredited Investor thresholds and QEP Portfolio Requirement are not expressed in precisely identical terms, but all Accredited Investors are eligible to participate in Rule 4.13(a)(3) vehicles under CFTC Rule 4.13(a)(3)(iii)(A).

    [5] A Section 3(c)(1) fund is a pooled investment vehicle that is excluded from the definition of investment company in the Investment Company Act because it has no more than 100 beneficial owners (or, in the case of a qualifying venture capital fund, 250 beneficial owners) and otherwise meets criteria outlined in Section 3(c)(1) of the Investment Company Act. 


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2024 Schulte Roth & Zabel LLP. All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Daniel F. Hunter

    Partner

    New York – 919 Third Avenue

    More insights